Autoinjector USA patent approval..8 Sep 2009 08:05
This drug delivery specialist, is pleased to announce that it has now received its first two Notices of Allowance from the US Patent and Trade Mark Office in respect of patents relating to its ASITM autoinjector device technology.
Ian Townsend, Chairman, The Medical House PLC, said: "These are extremely significant milestones for our company as successful US patent applications underpin our ability to out-license our ASITM autoinjector technology to our international client base. These patent approvals increase the likelihood of signing further licensing agreements for this key self-injection technology."On 12 August TMH announced that it had received an approach which may or may not lead to an offer for the Company. A further announcement will be made in due course.Brief description of ASITM.The ASITM autoinjector technology enables patients to undertake a completely automated injection, including needle insertion and medication injection to needle withdrawal and safe retraction back into the device. When the injection is completed, the entire device unit is disposable. With an ASITM autoinjector device, patients never see or handle a needle, thereby reducing the anxiety that many people have about self-injection and eliminating the risk of accidental needlestick injuries.